The Samsung Galaxy Watch3 announced three days ago is receiving its first software update, which enables a couple of features that aren’t activated out of the box – VO2 Max and blood oxygen monitoring. The last one isn’t available in nine countries, though, which include Algeria, Angola, Canada, France, Iran, Japan, Libya, South Africa and Thailand.
Seeing how the governments across the world are busy battling the COVID-19 pandemic right now, it could be a while before ECG and blood pressure monitoring is activated on the Galaxy Watch3.
The Samsung Galaxy Watch3 is powered by the Exynos 9110 SoC and boots to Tizen OS 5.5. It packs a Super AMOLED display and comes in two sizes – 41mm and 45mm – with the screen measuring 1.2″ and 1.4″, respectively.
You can read our full Galaxy Watch3 announcement coverage to know more about it.
The Galaxy Watch3 also features hardware to measure blood pressure and electrocardiogram (ECG) readings, but these functions aren’t activated right now due to the pending approvals from regulatory agencies of different countries. This was also the case with the Galaxy Watch Active2 announced last August, which got ECG enabled yesterday.